Travere Therapeutics, Inc. TVTX Other Income (Expense)
Other Income (Expense) at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Travere Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Travere Therapeutics, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Travere Therapeutics, Inc.'s other income (expense)?
- Travere Therapeutics, Inc. (TVTX) reported other income (expense) of $193K in Q1 2026.
- How has Travere Therapeutics, Inc.'s other income (expense) changed year-over-year?
- Travere Therapeutics, Inc.'s other income (expense) decreased by 87.0% year-over-year, from $1.49M to $193K.
- What is the long-term trend for Travere Therapeutics, Inc.'s other income (expense)?
- Over 3 years (2021 to 2025), Travere Therapeutics, Inc.'s other income (expense) has grown at a -8.1% compound annual growth rate (CAGR), from -$17.46M to $13.55M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.